Document is current
Any future updates will be listed below
-
Authors
Sturmlechner, Ines https://orcid.org/0000-0003-1272-5618
Sine, Chance C.
Jeganathan, Karthik B.
Zhang, Cheng
Fierro Velasco, Raul O. https://orcid.org/0000-0003-4889-128X
Baker, Darren J. https://orcid.org/0000-0001-9006-1939
Li, Hu https://orcid.org/0000-0001-5957-5472
van Deursen, Jan M. https://orcid.org/0000-0002-3042-5267
-
Funding
Funding for this research was provided by:
Glenn Foundation for Medical Research
W. M. Keck Foundation
- License Information
-
More Information
Article History
Received: 9 June 2021
Accepted: 9 June 2022
First Online: 28 June 2022
Competing interests
: J.M.v.D. is a co-founder of and holds equity in Unity Biotechnology (a company developing senolytic medicines), and Cavalry Biosciences. J.M.v.D. and D.J.B. are inventors on patents licensed to or filed by Unity Biotechnology. All other authors declare no competing interest. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic conflict of interest policies.
